Charles Lockwood has advanced stage liver cancer and was taken off the transplant list after a new tumor appeared in another part of his body. He underwent a new treatment called Therasphere to shrink the tumor, and is now able to enjoy the time he has left.

With his health fading, Charles Lockwood was running out of time and options.

Charles has advanced stage liver cancer and because a new tumor popped up in another part of his body, he was taken off the liver transplant list.

"Eventually I'm going to die," Charles said.

Rather than do nothing, Charles became one of the first patients to undergo a new treatment at the Wilmot Cancer Center, performed at only 50 select hospitals across the country.

The treatment is called Therasphere, and it works by using radioactive glass beads, fed through the blood stream with a catheter, to attack and ultimately shrink a liver tumor.

"Basically a way for us to give very high doses of radiation into the liver," said Dr. David Waldman of the University of Rochester Medical Center.

This technology can work well enough to get some patients back on the transplant list, but others have more modest results.

"I will not say that there haven't been cures, but I would say that for the majority of patients it just does extend the life," said Dr. Waldman.

After months of planning, the procedure only took a few hours. Charles was sent home the same day to recover.

"There was nothing to it,” Charles said.

A few weeks later he is feeling better than he has in a long time.

"I mean I feel like I'm almost normal," he said.

A great way, Charles said, to spend the time he has left.

"Best quality of life, a little more time that's about it," he said.